GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-8.59 Cr | ₹-13 Cr | ₹-14 Cr | ₹-5.16 Cr | ₹2.10 Cr |
What is the latest Cash Flow from Financing Activities ratio of GUJARAT THEMIS BIOSYN ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-8.59 Cr |
Mar2023 | ₹-13 Cr |
Mar2022 | ₹-14 Cr |
Mar2021 | ₹-5.16 Cr |
Mar2020 | ₹2.10 Cr |
How is Cash Flow from Financing Activities of GUJARAT THEMIS BIOSYN Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.59 Cr | Negative | |
Mar2023 | ₹-13 Cr | Negative | |
Mar2022 | ₹-14 Cr | Negative | |
Mar2021 | ₹-5.16 Cr | Negative | |
Mar2020 | ₹2.10 Cr | - |
Compare Cash Flow from Financing Activities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹3,579.6 Cr | 0.1% | 14.8% | 173.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,478.0 Cr | -1.3% | -4.8% | 45% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,822.0 Cr | 0.5% | 6.4% | 58.2% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.1% | 3.8% | 24.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,322.0 Cr | -0.6% | -5.7% | 5.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,217.3 Cr | 0.1% | -3.6% | 48.2% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | 0.1% |
14.8% |
173.2% |
SENSEX | 0.9% |
-0.3% |
20.9% |
You may also like the below Video Courses